1. Is it wise to target the late costimulatory molecule OX40 as a therapeutic target?

   • Mary Miranda Cavanagh
   • Tracy Hussell

   REVIEW 06 October 2008 Pages: 291 - 297

2. Opiate abuse, innate immunity, and bacterial infectious diseases

   • Jinghua Wang
   • Roderick A. Barke
   • Sabita Roy

   REVIEW 06 October 2008 Pages: 299 - 309

3. Antigen-nonspecific activation of CD8⁺ T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer

   • Sheela Ramanathan
   • Julien Gagnon
   • Subburaj Ilangumaran

   REVIEW 06 October 2008 Pages: 311 - 323

4. Mesenchymal stromal cells: tissue engineers and immune response modulators

   • Lieke C. J. van den Berk
   • Carl G. Figdor
   • Ruurd Torensma

   REVIEW 06 October 2008 Pages: 325 - 329

5. Structure and physiological functions of the human peroxisome proliferator-activated receptor γ

   • Andrzej Zieleniak
   • Marzena Wójcik
   • Lucyna A. Woźniak

   REVIEW 06 October 2008 Pages: 331 - 345

6. Immunochemical studies of the lipopolysaccharides of Hafnia alvei PCM 1219 and other strains with the O-antigens containing D-glucose 1-phosphate and 2-deoxy-2-[(R)-3-hydroxybutyramido]-D-glucose

   • Ewa Katzenellenbogen
   • Nina A. Kocharova
   • Yuriy A. Knirel

   ORIGINAL ARTICLE Open access 06 October 2008 Pages: 347 - 352